Response rate as an endpoint in clinical trials.
George
Stephen L
SL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D017326:Clinical Trials, Phase III as Topic; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005060:Europe / Q000453:epidemiology; D006801:Humans; D015337:Multicenter Studies as Topic; D012516:Osteosarcoma / Q000188:drug therapy / Q000401:mortality / Q000473:pathology*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome